theDealStream provides an AI‑driven platform that creates healthcare due‑diligence reports in about an hour, matching the depth of a multi‑hundred‑hour manual analysis. Using its Warner‑Starke Return On Value scoring across innovation, team, impact, and investment metrics, it delivers tiered reports (Screener, Executive Summary, DeepDive) to help venture capital and corporate investors evaluate med‑tech, biotech, and digital health startups quickly and rigorously.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare investors must analyze extensive clinical, regulatory, financial, and market data to assess startup viability, a process that often requires hundreds of hours of expert due diligence and can delay capital allocation decisions.
Solution
theDealStream offers an AI-powered platform that generates comprehensive healthcare due diligence reports in roughly one hour, replicating the depth of a 200‑hour manual analysis. Its proprietary Warner‑Starke Return On Value (ROV) methodology scores startups across four dimensions—Innovation, Individuals, Impact, and Investment—providing a multi‑dimensional risk‑adjusted rating. The service delivers three report tiers (Screener, Executive Summary, DeepDive) that align with different stages of the investment funnel, from initial sourcing to final decision. By automating data collection, scoring, and narrative synthesis, the platform enables investors to make faster, data‑driven capital allocation decisions while maintaining rigorous analytical standards.
Target Audience
Primary customers are venture capital firms, corporate venture arms, and healthcare-focused angel investors who require rapid, rigorous due diligence on med‑tech, biotech, and digital health startups.
Features
- AI-driven data aggregation and analysis that compresses weeks of research into a one‑hour workflow
- Warner‑Starke ROV scoring framework integrating innovation novelty, team quality, patient impact, and financial metrics
- Three tiered report formats: 1‑page Screener, 15‑page Executive Summary, and comprehensive DeepDive with red‑flag registry, exit modeling, and reimbursement analysis
- Automated technology architecture breakdown and due‑diligence question framework to surface critical risks
- Sector‑specific models trained on thousands of healthcare startup outcomes for calibrated scoring
- Exportable reports and scores that can be incorporated into existing investment pipelines